Supply High Quality turmeric powder

I. Overview

1. Chemical Structure and Source

2. 
   Curcumin is a natural polyphenolic compound extracted from the rhizomes of Curcuma longa (Zingiberaceae family). Its chemical name is 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione, with a molecular formula of C₂₁H₂₀O₆ and a molecular weight of 368.38. Curcumin constitutes approximately 3%–6% of the rhizome's dry weight and is the primary pigment responsible for turmeric's yellow color.

3. Physicochemical Properties

   • Appearance: Orange-yellow to deep yellow crystalline powder with a characteristic turmeric aroma.
   • Solubility: Poorly soluble in water; readily soluble in organic solvents (e.g., ethanol, acetone, glacial acetic acid).
   • Stability: Sensitive to light, heat, and oxygen; prone to degradation. Requires storage in airtight containers away from light.
   • Bioavailability: Low oral absorption and rapid metabolism (half-life: ~1–2 hours). Dosage form modifications are needed to enhance bioavailability.
   • 
     

4. Safety

   • Toxicity: Oral LD₅₀ in rats > 2 g/kg; classified as GRAS (Generally Recognized as Safe) by the FDA.
   • Clinical Studies: No significant adverse effects reported at doses up to 12 g/day for ≤8 months. Long-term safety requires further investigation.

II. Pharmacological Effects

1. Anti-inflammatory Activity
   Inhibits NF-κB, MAPK, STAT3 signaling pathways, reducing pro-inflammatory cytokines (e.g., TNF-α, IL-6). Clinical trials demonstrate efficacy in alleviating symptoms of osteoarthritis and rheumatoid arthritis.

2. Antioxidant Activity
   Scavenges free radicals (e.g., ROS, RNS) and induces antioxidant enzyme expression (e.g., SOD, CAT, GPx). Animal models show protection against oxidative stress-induced damage in liver, kidney, and brain.

3. Antitumor Activity
   Suppresses tumor cell proliferation, induces apoptosis, and inhibits angiogenesis and metastasis. Demonstrates activity against various cancers (e.g., breast, colorectal, pancreatic). Combination with chemotherapy enhances efficacy in clinical trials.

4. Neuroprotective Effects
   Inhibits amyloid-β (Aβ) aggregation and mitigates cognitive deficits in Alzheimer's disease models. Protects neurons against glutamate toxicity, oxidative stress, and inflammation.

5. Other Effects

   • Hypolipidemic: Inhibits cholesterol synthesis and promotes bile acid excretion.
   • Hepatoprotective: Attenuates alcoholic liver injury and inhibits hepatic fibrosis.
   • Antimicrobial: Inhibits Staphylococcus aureus and Escherichia coli.

III. Clinical Applications

1. Inflammatory Disorders
   • Osteoarthritis: Clinical trials report reduced joint pain and improved function.
   • Ulcerative Colitis: Combination with mesalazine enhances remission rates.
   • 
     
2. Metabolic Diseases
   • Diabetes: Improves insulin resistance and lowers fasting blood glucose and HbA1c.
   • Non-Alcoholic Fatty Liver Disease: Reduces hepatic steatosis and inflammation.
   • 
     
3. Oncological Supportive Care
   • Pancreatic Cancer: Prolongs survival when combined with gemcitabine.
   • Colorectal Cancer: Alleviates chemotherapy-related adverse effects.
   • 
     
4. Neurological Disorders
   • Alzheimer's Disease: Clinical trials suggest cognitive improvement but require further validation.
   • Depression: Animal studies show antidepressant effects; clinical results are inconsistent.
   • 
     
   • Dermatological Conditions

5. • Psoriasis: Topical application reduces erythema and scaling.

   • Vitiligo: Combination with phototherapy enhances repigmentation.